WO1999032621A3 - Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof - Google Patents
Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof Download PDFInfo
- Publication number
- WO1999032621A3 WO1999032621A3 PCT/US1998/025478 US9825478W WO9932621A3 WO 1999032621 A3 WO1999032621 A3 WO 1999032621A3 US 9825478 W US9825478 W US 9825478W WO 9932621 A3 WO9932621 A3 WO 9932621A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- src
- nuclear receptor
- steroid
- receptor
- nucleic acid
- Prior art date
Links
- 102000011244 Nuclear receptor coactivator Human genes 0.000 title 1
- 108050001461 Nuclear receptor coactivator Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical group 0.000 title 1
- 102000004970 Nuclear Receptor Coactivator 3 Human genes 0.000 abstract 9
- 108090001145 Nuclear Receptor Coactivator 3 Proteins 0.000 abstract 9
- 108020005497 Nuclear hormone receptor Proteins 0.000 abstract 2
- 102000007451 Steroid Receptors Human genes 0.000 abstract 2
- 108010085012 Steroid Receptors Proteins 0.000 abstract 2
- 102000006255 nuclear receptors Human genes 0.000 abstract 2
- 108020004017 nuclear receptors Proteins 0.000 abstract 2
- 230000035897 transcription Effects 0.000 abstract 2
- 238000013518 transcription Methods 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 101100098709 Caenorhabditis elegans taf-1 gene Proteins 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000003081 coactivator Effects 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 abstract 1
- 238000002005 protein protein interaction detection Methods 0.000 abstract 1
- 238000002762 protein-protein interaction assay Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU18010/99A AU1801099A (en) | 1997-12-22 | 1998-12-01 | Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6851197P | 1997-12-22 | 1997-12-22 | |
US60/068,511 | 1997-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999032621A2 WO1999032621A2 (en) | 1999-07-01 |
WO1999032621A3 true WO1999032621A3 (en) | 1999-09-16 |
Family
ID=22083052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/025478 WO1999032621A2 (en) | 1997-12-22 | 1998-12-01 | Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1801099A (en) |
WO (1) | WO1999032621A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022094501A1 (en) | 2020-10-28 | 2022-05-05 | Baylor College Of Medicine | Targeting of src-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997010337A1 (en) * | 1995-09-15 | 1997-03-20 | Baylor College Of Medicine | Steroid receptor coactivator compositions and methods of use |
WO1998002455A2 (en) * | 1996-07-12 | 1998-01-22 | Institut National De La Sante Et De La Recherche Medicale | Transcriptional intermediary factor-2 (tfif2) |
WO1998057982A2 (en) * | 1997-06-17 | 1998-12-23 | The United States Of America, Represented By The | Aib1, a steroid receptor co-activator |
-
1998
- 1998-12-01 WO PCT/US1998/025478 patent/WO1999032621A2/en active Application Filing
- 1998-12-01 AU AU18010/99A patent/AU1801099A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997010337A1 (en) * | 1995-09-15 | 1997-03-20 | Baylor College Of Medicine | Steroid receptor coactivator compositions and methods of use |
WO1998002455A2 (en) * | 1996-07-12 | 1998-01-22 | Institut National De La Sante Et De La Recherche Medicale | Transcriptional intermediary factor-2 (tfif2) |
WO1998057982A2 (en) * | 1997-06-17 | 1998-12-23 | The United States Of America, Represented By The | Aib1, a steroid receptor co-activator |
Non-Patent Citations (13)
Title |
---|
A TAKESHITA ET AL: "TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 44, 31 October 1997 (1997-10-31), pages 27629 - 27634, XP002088095, ISSN: 0021-9258 * |
CHEN H ET AL: "NUCLEAR RECEPTOR COACTIVATOR ACTR IS A NOVEL HISTONE ACETYLTRANSFERASE AND FORMS A MULTIMERIC ACTIVATION COMPLEX WITH P/CAF AND CBP/P300", CELL, vol. 90, 8 August 1997 (1997-08-08), pages 569 - 580, XP002910264, ISSN: 0092-8674 * |
HONG H ET AL: "GRIP1, A TRANSCRIPTIONAL COACTIVATOR FOR THE AF-2 TRANSACTIVATION DOMAIN OF STEROID, THYROID, RETINOID, AND VITAMIN D RECEPTORS", MOLECULAR AND CELLULAR BIOLOGY, vol. 17, no. 5, 1 May 1997 (1997-05-01), pages 2735 - 2744, XP002045758, ISSN: 0270-7306 * |
J TORCHIA ET AL: "The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function", NATURE, vol. 387, no. 6634, 12 June 1997 (1997-06-12), pages 677 - 684, XP002088153, ISSN: 0028-0836 * |
KIM HAN-JONG ET AL.,: "Molecular cloning of xSRC-3, a novel transcription coactivator factor from xenopus, that is related to AIB1, p/CIP, and TIF2", MOLECULAR ENDOCRINOLOGY, vol. 12, no. 7, 1 July 1998 (1998-07-01), pages 1038 - 1047, XP002109674 * |
LI H ET AL: "RAC3, A STEROID/NUCLEAR RECEPTOR-ASSOCIATED COACTIVATOR THAT IS RELATED TO SRC-1 AND TIF2", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 94, August 1997 (1997-08-01), pages 8479 - 8484, XP002910265, ISSN: 0027-8424 * |
ONATE S A ET AL: "SEQUENCE AND CHARACTERIZATION OF A COACTIVATOR FOR THE STEROID HORMONE RECEPTOR SUPERFAMILY", SCIENCE, vol. 270, 24 November 1995 (1995-11-24), pages 1354 - 1357, XP002911375, ISSN: 0036-8075 * |
S L ANZICK ET AL: "AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer", SCIENCE, vol. 277, no. 5328, 15 August 1997 (1997-08-15), pages 965 - 968, XP002088093, ISSN: 0036-8075 * |
SHUGHRUE P J ET AL: "Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract", STEROIDS: STRUCTURE, FUNCTION, AND REGULATION, vol. 63, no. 10, 1 October 1998 (1998-10-01), pages 498-504, XP004140830, ISSN: 0039-128X * |
SUEN CHEN-SHIAN ET AL.,: "A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 42, 16 October 1998 (1998-10-16), pages 27645-27653, XP002109675 * |
VOEGEL J J ET AL: "TIF2, A 160 KDA TRANSCRIPTIONAL MEDIATOR FOR THE LIGAND-DEPENDENT ACTIVATION FUNCTION AF-2 OF NUCLEAR RECEPTORS", EMBO JOURNAL, vol. 15, no. 14, 1 January 1996 (1996-01-01), pages 3667 - 3675, XP002045757, ISSN: 0261-4189 * |
WITKOWSKA H E ET AL: "Characterization of bacterially expressed rat estrogen receptor beta ligand binding domain by mass spectrometry: Structural comparison with estrogen receptor alpha", STEROIDS: STRUCTURE, FUNCTION, AND REGULATION, vol. 62, no. 8-9, 9 August 1997 (1997-08-09), pages 621-631, XP004091560, ISSN: 0039-128X * |
X-Y GUAN ET AL: "Hybrid selection of transcribed sequences from microdissected DNA: Isolation of genes within an amplified region at 20q11-q13.2 in breast cancer", CANCER RESEARCH, vol. 56, no. 15, 1 August 1996 (1996-08-01), pages 3446 - 3450, XP002088091, ISSN: 0008-5472 * |
Also Published As
Publication number | Publication date |
---|---|
AU1801099A (en) | 1999-07-12 |
WO1999032621A2 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Croxton et al. | Direct repression of the Mcl-1 promoter by E2F1 | |
Pabst et al. | AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t (8; 21) myeloid leukemia | |
Rizos et al. | Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization | |
Dauphinot et al. | Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression | |
Hittelman et al. | Differential regulation of glucocorticoid receptor transcriptional activation via AF‐1‐associated proteins | |
Jung et al. | Novel transcription coactivator complex containing activating signal cointegrator 1 | |
Schuh et al. | ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis | |
Bai et al. | ZBP-89 promotes growth arrest through stabilization of p53 | |
HUP9700636A2 (en) | Novel estrogen receptor | |
DK0914345T3 (en) | Antibodies that bind to monocyte chemoattractant protein-1 receptor (MCP-1 receptor) (CCR2) | |
Di Croce et al. | Steroid and nuclear receptors Villefranche‐sur‐Mer, France, May 25–27, 1999 | |
Barlev et al. | A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription | |
Cohen‐Kaminsky et al. | Chromatin immunoselection defines a TAL‐1 target gene | |
Kim et al. | MDM2 regulates estrogen receptor α and estrogen-responsiveness in breast cancer cells | |
Gustafsson et al. | Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54) | |
Karetsou et al. | Prothymosin α associates with the oncoprotein SET and is involved in chromatin decondensation | |
Ito et al. | SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex | |
Natesampillai et al. | Regulation of Kruppel-like factor 4, 9, and 13 genes and the steroidogenic genes LDLR, StAR, and CYP11A in ovarian granulosa cells | |
WO1999032621A3 (en) | Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof | |
AU6639896A (en) | Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor | |
WO1998057982A3 (en) | Aib1, a steroid receptor co-activator | |
Herbert et al. | Distribution of androgen-binding protein in the rat hypothalamo-neurohypophyseal system, co-localization with oxytocin | |
Yang et al. | Ras signaling is involved in the expression of Fas-L in glioma | |
Tong et al. | JEM-1, a novel nuclear co-factor: localisation and functional interaction with AP-1 | |
Potter et al. | Purification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 gene. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |